NEUBASE THERAPEUT. DL-,01 Aktie - Unternehmensdaten & Kurse - US64132K2015 | goSPATZ

NEUBASE THERAPEUT. DL-,01

Share · US64132K2015 · NBSE · A3EHBD (XNCM)

Overview Financial Indicators

No Price

n/a

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-	-	-	-	-2,73 %	-0,43 %	-99,74 %

Company Profile for NEUBASE THERAPEUT. DL-,01 Share

NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1; NT0300, a PATrOL-enabled therapeutic treatment to target the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.

Company Data

Name NEUBASE THERAPEUT. DL-,01

Company NeuBase Therapeutics, Inc.

Symbol NBSE

Website https://www.neubasetherapeutics.com

Primary Exchange

Frankfurt

WKN A3EHBD

ISIN US64132K2015

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Todd P. Branning

Country United States of America

Currency EUR

Employees 0,0 T

Address 350 Technology Drive, 15219 Pittsburgh

IPO Date 2004-05-28

ID Changes

Date	From	To
16.07.2019	OHRP	NBSE

Ticker Symbols

Name	Symbol
NASDAQ	NBSE

More Shares

Investors who NEUBASE THERAPEUT. DL-,01 hold also have the following shares in their portfolio:

IMMSI S.P.A. Share

JOHN DEE. BK 24/29 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025